{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:45:07Z","timestamp":1786995907369,"version":"build-2736575974"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T00:00:00Z","timestamp":1428364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Multidisciplinary Association for Psychedelic Studies (MAPS)"},{"name":"Clinical Research Scientist and monitors the study"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.pnpbp.2015.03.011","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T05:56:52Z","timestamp":1428559012000},"page":"237-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults"],"prefix":"10.1016","volume":"64","author":[{"given":"Alicia L.","family":"Danforth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Struble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berra","family":"Yazar-Klosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2015.03.011_bb0005","series-title":"The use of LSD in psychotherapy: transactions of a conference on d-lysergic acid diethylamide (LSD-25)","author":"Abramson","year":"1960"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0010","first-page":"59","article-title":"The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice","volume":"10","author":"Adamson","year":"1988","journal-title":"Revision"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1162\/089892901564289","article-title":"Abnormal processing of social information from faces in autism","volume":"13","author":"Adolphs","year":"2001","journal-title":"J Cogn Neurosci"},{"issue":"7021","key":"10.1016\/j.pnpbp.2015.03.011_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature03086","article-title":"A mechanism for impaired fear recognition after amygdala damage","volume":"433","author":"Adolphs","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1037\/h0080376","article-title":"On redefining hallucination","volume":"68","author":"Aleman","year":"1998","journal-title":"Am J Orthopsychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0030","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropsychologia.2006.04.014","article-title":"Differential activation of the amygdala and the \u201csocial brain\u201d during fearful face-processing in Asperger syndrome","volume":"45","author":"Ashwin","year":"2007","journal-title":"Neuropsychologia"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/17470910802337902","article-title":"Positive and negative gaze perception in autism spectrum conditions","volume":"4","author":"Ashwin","year":"2009","journal-title":"Soc Neurosci"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0045","author":"Baggott"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1471-4159.2004.02763.x","article-title":"Serotonin\u2013GABA interactions modulate MDMA\u2010induced mesolimbic dopamine release","volume":"91","author":"Bankson","year":"2004","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/109830070100300305","article-title":"Attributional style and depression in adolescents with Asperger syndrome","volume":"3","author":"Barnhill","year":"2001","journal-title":"J Posit Behav Interv"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.yhbeh.2006.06.018","article-title":"The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior","volume":"50","author":"Bartz","year":"2006","journal-title":"Horm Behav"},{"issue":"9","key":"10.1016\/j.pnpbp.2015.03.011_bb0065","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10803-010-1157-x","article-title":"Diagnosing autism spectrum disorders in adults: the use of Autism Diagnostic Observation Schedule (ADOS) module 4","volume":"41","author":"Bastiaansen","year":"2011","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-006-0322-6","article-title":"3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings","volume":"189","author":"Baumann","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.pnpbp.2015.03.011_bb0075","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1124\/dmd.109.028506","article-title":"Effects of dose and route of administration on pharmacokinetics of (\u00b1)-3,4-methylenedioxymethamphetamine in the rat","volume":"37","author":"Baumann","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J Pers Assess"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","article-title":"Effects of MDMA on sociability and neural response to social threat and social reward","volume":"207","author":"Bedi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.pnpbp.2015.03.011_bb0090","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.biopsych.2010.08.003","article-title":"Is Ecstasy an \u201cempathogen\u201d? Effects of \u00b13,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others","volume":"68","author":"Bedi","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/978-1-4684-8306-2_17","article-title":"Treatment of autistic schizophrenic children with LSD-25 and UML-491","volume":"4","author":"Bender","year":"1962","journal-title":"Recent Adv Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0095","first-page":"84","article-title":"LSD and UML treatment of hospitalized disturbed children","volume":"5","author":"Bender","year":"1963","journal-title":"Recent Adv Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1352465808004190","article-title":"Mindfulness training for adolescents with externalizing disorders and their parents","volume":"36","author":"B\u00f6gels","year":"2008","journal-title":"Behav Cogn Psychother"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","article-title":"MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder","volume":"40","author":"Bouso","year":"2008","journal-title":"J Psychoactive Drugs"},{"issue":"14","key":"10.1016\/j.pnpbp.2015.03.011_bb0115","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1997.tb52356.x","article-title":"Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice","volume":"836","author":"Brunner","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","article-title":"Human pharmacology of 3, 4-methylenedioxymeth-amphetamine (\u201cEcstasy\u201d): psychomotor performance and subjective effects","volume":"20","author":"Cam\u00ed","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1362361307070992","article-title":"Tics and Tourette syndrome in autism spectrum disorders","volume":"11","author":"Canitano","year":"2007","journal-title":"Autism"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000111555","article-title":"Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive\u2013compulsive disorder in adults: a preliminary case-controlled study","volume":"41","author":"Cath","year":"2008","journal-title":"Psychopathology"},{"issue":"6988","key":"10.1016\/j.pnpbp.2015.03.011_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/429126a","article-title":"Psychedelic drugs: the ups and downs of Ecstasy","volume":"429","author":"Check","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00005053-195509000-00001","article-title":"Clinical reactions and tolerance to LSD in chronic schizophrenia","volume":"122","author":"Cholden","year":"1955","journal-title":"J Nerv Ment Dis"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1037\/a0014124","article-title":"Autism and the extraction of emotion from briefly presented facial expressions: stumbling at the first step of empathy","volume":"8","author":"Clark","year":"2008","journal-title":"Emotion"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0149-7634(03)00031-9","article-title":"The pre-clinical behavioural pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA)","volume":"27","author":"Cole","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.neuroscience.2006.06.033","article-title":"Effects of (\u00b1) 3, 4-methylenedioxymethamphetamine,(\u00b1) 3, 4-methylenedioxy- amphetamine and methamphetamine on temperature and activity in rhesus macaques","volume":"142","author":"Crean","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0180","series-title":"Courage, connection, and clarity: a mixed-methods collective-case study of MDMA (Ecstasy) experiences of autistic adults (Doctoral dissertation)","author":"Danforth","year":"2013"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0185","first-page":"352","article-title":"Ecstasy","volume":"vol. 1","author":"Danforth","year":"2009"},{"issue":"7","key":"10.1016\/j.pnpbp.2015.03.011_bb0190","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/14649360802382586","article-title":"Autistic culture online: virtual communication and cultural expression on the spectrum","volume":"9","author":"Davidson","year":"2008","journal-title":"Soc Cult Geogr"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0195","first-page":"85","article-title":"A multidimensional approach to individual differences in empathy","volume":"10","author":"Davis","year":"1980","journal-title":"Cat Sel Doc Psychol"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1037\/0022-3514.44.1.113","article-title":"Measuring individual differences in empathy: evidence for a multidimensional approach","volume":"44","author":"Davis","year":"1983","journal-title":"J Pers Soc Psychol"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-005-0255-5","article-title":"Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns","volume":"189","author":"De La Garza","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb9995","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre","year":"2004","journal-title":"Therapeutic drug monitoring"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/02791072.2002.10399952","article-title":"A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA","volume":"34","author":"Doblin","year":"2002","journal-title":"J Psychoactive Drugs"},{"issue":"10","key":"10.1016\/j.pnpbp.2015.03.011_bb0215","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biopsych.2007.03.025","article-title":"Ot attenuates amygdala responses to emotional faces regardless of valence","volume":"62","author":"Domes","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0220","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","article-title":"Oxytocin improves \u201cmind-reading\u201d in humans","volume":"61","author":"Domes","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/02791072.1986.10472366","article-title":"The psychological and physiological effects of MDMA on normal volunteers","volume":"18","author":"Downing","year":"1986","journal-title":"J Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.pnpbp.2015.03.011_bb0235","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.amjcard.2007.06.045","article-title":"Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease","volume":"100","author":"Droogmans","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0240","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1440-1614.2001.0905h.x","article-title":"Mood stabilizers in Asperger's syndrome","volume":"35","author":"Duggal","year":"2001","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0250","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0269881106063271","article-title":"A review of acute effects of 3, 4-methylenedioxymethamphetamine in healthy volunteers","volume":"20","author":"Dumont","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17470910802649470","article-title":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration","volume":"4","author":"Dumont","year":"2009","journal-title":"Soc Neurosci"},{"issue":"3-4","key":"10.1016\/j.pnpbp.2015.03.011_bb0255","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","article-title":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","volume":"173","author":"Farr\u00e9","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0260","series-title":"Structured clinical interview for DSM-IV\u00ae axis I disorders (SCID-I), clinician version, administration booklet","author":"First","year":"2012"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0265","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/002076407001600204","article-title":"The psycholytic treatment of a childhood schizophrenic girl","volume":"16","author":"Fisher","year":"1970","journal-title":"Int J Soc Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0270","unstructured":"Fisher, G., & Castile, D. (1963). Interim report on research project: An investigation to determine therapeutic effectiveness of LSD-25 and psilocybin on hospitalized severely emotionally disturbed children. Unpublished manuscript."},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.159.1.13","article-title":"Treating a child with Asperger's disorder and comorbid bipolar disorder","volume":"159","author":"Frazier","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0280","first-page":"35","article-title":"Autistic schizophrenic children: an experiment in the use of d-lysergic acid diethylamide (LSD-25)","volume":"6","author":"Freedman","year":"1961","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0285","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","article-title":"3, 4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H215O]-PET in healthy humans","volume":"23","author":"Gamma","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0290","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1744629507083585","article-title":"Levels of anxiety and sources of stress in adults with autism","volume":"11","author":"Gillott","year":"2007","journal-title":"J Intellect Disabil"},{"issue":"9","key":"10.1016\/j.pnpbp.2015.03.011_bb0295","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp.56.9.1036","article-title":"Subarachnoid haemorrhage associated with MDMA abuse","volume":"56","author":"Gledhill","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0300","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0091-3057(00)00174-X","article-title":"MDMA stimulus generalization to the 5-HT 1A serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin","volume":"66","author":"Glennon","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pbb.2007.01.007","article-title":"N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3, 4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats","volume":"86","author":"Glennon","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","article-title":"Role of 5-HT in stress, anxiety, and depression","volume":"54","author":"Graeff","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0325","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","article-title":"Subjective reports of the effects of MDMA in a clinical setting","volume":"18","author":"Greer","year":"1986","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0330","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/02791072.1998.10399713","article-title":"A method of conducting therapeutic sessions with MDMA","volume":"30","author":"Greer","year":"1998","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0335","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/appi.psychotherapy.1986.40.3.393","article-title":"Can drugs be used to enhance the psychotherapeutic process?","volume":"40","author":"Grinspoon","year":"1986","journal-title":"Am J Psychother"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0955-3959(98)00008-5","article-title":"MDMA research: preliminary investigations with human subjects","volume":"9","author":"Grob","year":"1998","journal-title":"Int J Drug Policy"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/16066350008998989","article-title":"Deconstructing Ecstasy: the politics of MDMA research","volume":"8","author":"Grob","year":"2000","journal-title":"Addict Res"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0350","first-page":"97","article-title":"The enigma of Ecstasy: implications for youth and society","volume":"29","author":"Grob","year":"2005","journal-title":"Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0355","series-title":"Substance abuse: a comprehensive textbook","first-page":"374","article-title":"MDMA","author":"Grob","year":"1995"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0360","first-page":"103","article-title":"Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations","volume":"73","author":"Grob","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0370","series-title":"LSD psychotherapy","author":"Grof","year":"1980"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0375","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1037\/0022-3514.85.2.348","article-title":"Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being","volume":"85","author":"Gross","year":"2003","journal-title":"J Pers Soc Psychol"},{"issue":"7","key":"10.1016\/j.pnpbp.2015.03.011_bb0380","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0400","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of \u2018Ecstasy\u2019(MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.pnpbp.2015.03.011_bb0390","doi-asserted-by":"crossref","first-page":"e10804","DOI":"10.1371\/journal.pone.0010804","article-title":"Amygdala engagement in response to subthreshold presentations of anxious face stimuli in adults with autism spectrum disorders: preliminary insights","volume":"5","author":"Hall","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0405","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0041-008X(73)80016-X","article-title":"Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals","volume":"25","author":"Hardman","year":"1973","journal-title":"Toxicol Appl Pharmacol"},{"issue":"18","key":"10.1016\/j.pnpbp.2015.03.011_bb0415","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/archinte.159.18.2221","article-title":"Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and \u03b3-hydroxybutyrate","volume":"159","author":"Harrington","year":"1999","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0425","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","article-title":"Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"162","author":"Harris","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.pnpbp.2015.03.011_bb0430","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881108094650","article-title":"Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA","volume":"23","author":"Hasler","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0435","series-title":"Social phobia clinical and research perspectives","first-page":"3","article-title":"Clinical phenomenology and co-morbidity","author":"Hazen","year":"1995"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0450","series-title":"Ecstasy, a complete guide","first-page":"71","article-title":"Medical risks associated with MDMA use","author":"Henry","year":"2001"},{"issue":"8816","key":"10.1016\/j.pnpbp.2015.03.011_bb0445","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0140-6736(92)91469-O","article-title":"Toxicity and deaths from 3,4-methylenedioxymethamphetamine (\u201c ecstasy\u201d)","volume":"340","author":"Henry","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0460","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0455","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","article-title":"Oxytocin increases retention of social cognition in autism","volume":"61","author":"Hollander","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0465","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","article-title":"A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders","volume":"169","author":"Hollander","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0470","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2004.06.006","article-title":"The acute and sub-acute effects of \u201cEcstasy\u201d (MDMA) on processing of facial expressions: preliminary findings","volume":"76","author":"Hoshi","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0475","doi-asserted-by":"crossref","DOI":"10.1177\/2050324513509190","article-title":"Ecstasy, legal highs and designer drug use: a Canadian perspective","volume":"1","author":"Hudson","year":"2014","journal-title":"Drug Sci Policy Law"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0480","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/emj.10.4.372","article-title":"Intracranial haemorrhage associated with ingestion of \u2018Ecstasy\u2019","volume":"10","author":"Hughes","year":"1993","journal-title":"Arch Emerg Med"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0269881106060513","article-title":"The sub-acute effects of recreational Ecstasy (MDMA) use: a controlled study in humans","volume":"20","author":"Huxster","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"8","key":"10.1016\/j.pnpbp.2015.03.011_bb0505","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/emj.2009.079905","article-title":"Effects of a \u03b2-blocker on the cardiovascular response to MDMA (Ecstasy)","volume":"27","author":"Hysek","year":"2010","journal-title":"Emerg Med J"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0495","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","article-title":"MDMA enhances \u201cmind reading\u201d of positive emotions and impairs \u201cmind reading\u201d of negative emotions","volume":"222","author":"Hysek","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0510","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2007.02.001","article-title":"Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism","volume":"417","author":"Jacob","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0515","author":"Jerome"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0520","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0269881109102787","article-title":"How could MDMA (Ecstasy) help anxiety disorders? A neurobiological rationale","volume":"23","author":"Johansen","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0525","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0530","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s10803-012-1679-5","article-title":"Psychiatric co-morbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study","volume":"43","author":"Joshi","year":"2012","journal-title":"J Autism Dev Disord"},{"issue":"11","key":"10.1016\/j.pnpbp.2015.03.011_bb0535","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-113-11-821","article-title":"Emergence of recreational drug abuse as a major risk factor for stroke in young adults","volume":"113","author":"Kaku","year":"1990","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0540","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0545","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism","volume":"66","author":"King","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"49","key":"10.1016\/j.pnpbp.2015.03.011_bb0550","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0555","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10879-010-9158-9","article-title":"Psychotherapy for individuals with autism spectrum disorders","volume":"41","author":"Koenig","year":"2011","journal-title":"J Contemp Psychother"},{"issue":"7042","key":"10.1016\/j.pnpbp.2015.03.011_bb0560","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0565","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0269881103174015","article-title":"Dissociable effects of a single dose of Ecstasy (MDMA) on psychomotor skills and attentional performance","volume":"17","author":"Lamers","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"198","key":"10.1016\/j.pnpbp.2015.03.011_bb0570","first-page":"36552","article-title":"Schedules of controlled substances; scheduling of 3,4-methylenedioxymethamphetamine (MDMA) into schedule I of the controlled substances act","volume":"51","author":"Lawn","year":"1986","journal-title":"Fed Regist"},{"issue":"10","key":"10.1016\/j.pnpbp.2015.03.011_bb0575","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.mp.4002087","article-title":"Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition","volume":"13","author":"Lerer","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2015.03.011_bb0580","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-133-12-200012190-00012","article-title":"Cardiovascular effects of 3, 4-methylenedioxymethamphetamine: a double-blind, placebo-controlled trial","volume":"133","author":"Lester","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0590","series-title":"When science goes wrong: twelve tales from the dark side of discovery","first-page":"78","author":"LeVay","year":"2008"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0595","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(02)00190-4","article-title":"Mental disorders in Ecstasy users: a prospective-longitudinal investigation","volume":"68","author":"Lieb","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.pnpbp.2015.03.011_bb0600","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archpsyc.1985.01790300097013","article-title":"Social phobia: review of a neglected anxiety disorder","volume":"42","author":"Liebowitz","year":"1985","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0610","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","article-title":"The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (\u2018Ecstasy\u2019) in healthy volunteers","volume":"14","author":"Liechti","year":"2000","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0620","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002130000648","article-title":"Gender differences in the subjective effects of MDMA","volume":"154","author":"Liechti","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"43\u201344","key":"10.1016\/j.pnpbp.2015.03.011_bb0630","first-page":"652","article-title":"Acute medical problems due to Ecstasy use","volume":"135","author":"Liechti","year":"2005","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0635","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005053-199206000-00001","article-title":"Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use","volume":"180","author":"Liester","year":"1992","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0640","series-title":"Cognitive-behavioral treatment of borderline personality disorder","author":"Linehan","year":"1993"},{"issue":"817","key":"10.1016\/j.pnpbp.2015.03.011_bb0655","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/pgmj.69.817.874","article-title":"Cerebral infarction in association with Ecstasy abuse","volume":"69","author":"Manchanda","year":"1993","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0660","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","article-title":"Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans","volume":"290","author":"Mas","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"24","key":"10.1016\/j.pnpbp.2015.03.011_bb0645","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1080\/09638280600646185","article-title":"Reliability and validity of The Awareness of Social Inference Test (TASIT): a clinical test of social perception","volume":"28","author":"McDonald","year":"2006","journal-title":"Disabil Rehabil"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0665","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300808","article-title":"Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons","volume":"31","author":"Mechan","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0670","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12024-010-9220-7","article-title":"\u201cEcstasy\u201d associated deaths: what is a fatal concentration? Analysis of a case series","volume":"7","author":"Milroy","year":"2011","journal-title":"Forensic Sci Med Pathol"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0680","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of \u00b13,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0685","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269881112456611","article-title":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study","volume":"27","author":"Mithoefer","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0690","first-page":"5","article-title":"The use of psychedelic agents with autistic schizophrenic children","volume":"10","author":"Mogar","year":"1969","journal-title":"Psychedelic Rev"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0695","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2125.2012.04252.x","article-title":"Valvular heart disease in a patient taking 3,4\u2010methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019)","volume":"74","author":"Montastruc","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2015.03.011_bb0700","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.pnpbp.2005.04.009","article-title":"Serotonin (1A) receptor involvement in acute 3, 4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat","volume":"29","author":"Morley","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0705","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/FTD.0b013e3181a4f6c2","article-title":"Direct comparison of (\u00b1)3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) disposition and metabolism in squirrel monkeys and humans","volume":"31","author":"Mueller","year":"2009","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0710","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.forsciint.2008.12.002","volume":"184","author":"Mueller","year":"2009","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0715","author":"Multidisciplinary Association for Psychedelic Studies"},{"issue":"10","key":"10.1016\/j.pnpbp.2015.03.011_bb0720","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s10803-008-0580-8","article-title":"Violent crime in Asperger syndrome: the role of psychiatric comorbidity","volume":"38","author":"Newman","year":"2008","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0725","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","article-title":"Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens: identification of a new therapeutic class: entactogens","volume":"18","author":"Nichols","year":"1986","journal-title":"J Psychoactive Drugs"},{"issue":"9752","key":"10.1016\/j.pnpbp.2015.03.011_bb0730","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0735","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2010.09.021","article-title":"Reduced GABA-A receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism","volume":"1380","author":"Oblak","year":"2012","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (\u00b13,4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0745","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1037\/0021-843X.96.3.223","article-title":"Age of onset in different phobias","volume":"96","author":"\u00d6st","year":"1987","journal-title":"J Abnorm Psychol"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0750","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-007-0703-5","article-title":"The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review","volume":"191","author":"Parrott","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0755","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/02791072.2014.873690","article-title":"The potential dangers of using MDMA for psychotherapy","volume":"46","author":"Parrott","year":"2014","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0765","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000147470","article-title":"Dance clubbing on MDMA and during abstinence from Ecstasy\/MDMA: prospective neuroendocrine and psychobiological changes","volume":"57","author":"Parrott","year":"2008","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0785","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0736-4679(99)00009-8","article-title":"Methamphetamine-related stroke: four cases","volume":"17","author":"Perez","year":"1999","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0790","first-page":"273","article-title":"Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users","volume":"1","author":"Peroutka","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0795","doi-asserted-by":"crossref","DOI":"10.1177\/0269881109102780","article-title":"An investigation of the subacute effects of Ecstasy on neuropsychological performance, sleep and mood in regular Ecstasy users","author":"Pirona","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"12","key":"10.1016\/j.pnpbp.2015.03.011_bb0775","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia\u2014Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0800","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1037\/0033-3204.42.4.483","article-title":"Better strangers: using the relationship in psychotherapy for adult patients with Asperger syndrome","volume":"42","author":"Ramsay","year":"2005","journal-title":"Psychother Theory Res Pract Train"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0810","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(94)90019-1","article-title":"A prospective follow\u2014along study of the course of social phobia","volume":"54","author":"Reich","year":"1994","journal-title":"Psychiatry Res"},{"issue":"5639","key":"10.1016\/j.pnpbp.2015.03.011_bb0820","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.301.5639.1479b","article-title":"Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (\u201cEcstasy\u201d): retraction","volume":"301","author":"Ricaurte","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb9910","first-page":"121","article-title":"LSD-assisted psychotherapy and the human encounter with death","volume":"4","author":"Richards","year":"1972","journal-title":"Journal of Transpersonal Psychology"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0825","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02791072.1994.10472600","article-title":"Psychedelic and entactogenic drugs in the treatment of depression","volume":"26","author":"Riedlinger","year":"1994","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0835","first-page":"497","article-title":"Tratamiento combinado deo psicoanalisis y LSD 25 en ninos psicoticos [Combined treatment with psychoanalysis and LSD 25 in psychotic children]","volume":"6","author":"Rojas-Berm\u00fadez","year":"1960","journal-title":"Acta Neuropsiquait (Argentina)"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0840","first-page":"552","article-title":"Preliminary method for study of LSD with children","volume":"1","author":"Rolo","year":"1965","journal-title":"Int J Neuropsychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0845","series-title":"Society and the adolescent self-image","author":"Rosenberg","year":"1965"},{"issue":"9","key":"10.1016\/j.pnpbp.2015.03.011_bb0855","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/jnnp.56.9.1035","article-title":"Cerebral venous sinus thrombosis induced by \u2018Ecstasy\u2019","volume":"56","author":"Rothwell","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0865","series-title":"Psychiatric and behavioural disorders in intellectual and developmental disabilities","first-page":"215","article-title":"Mental health problems in people with autism and related disorders","author":"Saulnier","year":"2007"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0870","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/0091-3057(86)90480-6","article-title":"Discriminative profile of MDMA","volume":"24","author":"Schechter","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"issue":"3-4","key":"10.1016\/j.pnpbp.2015.03.011_bb0875","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000253549","article-title":"MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research","volume":"60","author":"Schenk","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"8","key":"10.1016\/j.pnpbp.2015.03.011_bb0885","first-page":"322","article-title":"Functional impairment in social phobia","volume":"55","author":"Schneier","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0890","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02688699550041836","article-title":"Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations","volume":"9","author":"Selmi","year":"1995","journal-title":"Br J Neurosurg"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb0900","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3, 4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0905","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13638490601106277","article-title":"Flashback to the 1960s: LSD in the treatment of autism","volume":"10","author":"Sigafoos","year":"2007","journal-title":"Dev Neurorehabil"},{"issue":"11","key":"10.1016\/j.pnpbp.2015.03.011_bb0915","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1176\/ajp.122.11.1201","article-title":"Modification of autistic behavior with LSD-25","volume":"122","author":"Simmons","year":"1966","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2015.03.011_bb0910","first-page":"10","article-title":"The variable effects of LSD-25 on the behavior of a heterogeneous group of childhood schizophrenics","volume":"4","author":"Simmons","year":"1972","journal-title":"Behav Neuropsychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2015.03.011_bb0920","first-page":"149","article-title":"A case of MAO inhibitor\/MDMA interaction: agony after Ecstasy","volume":"25","author":"Smilkstein","year":"1987","journal-title":"Clin Toxicol"},{"issue":"8","key":"10.1016\/j.pnpbp.2015.03.011_bb0925","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1360-0443.1992.tb02003.x","article-title":"Recreational MDMA use in Sydney: a profile of \u2018Ecstasy\u2019 users and their experiences with the drug","volume":"87","author":"Solowij","year":"1992","journal-title":"Br J Addict"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0930","series-title":"Manual for the state-trait anxiety inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0935","series-title":"The secret chief revealed: conversations with a pioneer of the underground therapy movement","author":"Stolaroff","year":"2004"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb0940","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005053-199503000-00002","article-title":"Hallucinogenic drugs in psychiatric research and treatment: perspectives and prospects","volume":"183","author":"Strassman","year":"1995","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0945","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14\u20134863","author":"Substance Abuse Mental Health Services Administration","year":"2014"},{"issue":"5","key":"10.1016\/j.pnpbp.2015.03.011_bb0950","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0269881106060764","article-title":"The varieties of ecstatic experience: an exploration of the subjective experiences of Ecstasy","volume":"20","author":"Sumnall","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0955","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(01)00146-6","article-title":"The subjective effects of MDMA and mCPP in moderate MDMA users","volume":"65","author":"Tancer","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0960","series-title":"Autism and Asperger's syndrome","first-page":"147","article-title":"Asperger syndrome in adulthood","author":"Tantam","year":"1991"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0965","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1362361300004001004","article-title":"Psychological disorder in adolescents and adults with Asperger syndrome","volume":"4","author":"Tantam","year":"2000","journal-title":"Autism"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb0970","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuroscience.2007.02.032","article-title":"A role for oxytocin and 5-HT 1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (\u201cEcstasy\u201d)","volume":"146","author":"Thompson","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb0980","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/17470910802045042","article-title":"Neural correlates of MDMA (\u201cEcstasy\u201d)-induced social interaction in rats","volume":"4","author":"Thompson","year":"2009","journal-title":"Soc Neurosci"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb0990","series-title":"Stress and coping in autism","first-page":"2388","article-title":"Diagnosis and treatment of anxiety disorders in individuals with autism spectrum disorder","author":"Tsai","year":"2006"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb0995","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1037\/0021-843X.95.4.389","article-title":"Psychopathology of social phobia and comparison to avoidant personality disorder","volume":"95","author":"Turner","year":"1986","journal-title":"J Abnorm Psychol"},{"issue":"7","key":"10.1016\/j.pnpbp.2015.03.011_bb1000","doi-asserted-by":"crossref","first-page":"e40187","DOI":"10.1371\/journal.pone.0040187","article-title":"Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors","volume":"7","author":"van Wel","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pnpbp.2015.03.011_bb1005","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/ajp.151.9.1361","article-title":"Field trial for autistic disorder in DSM-IV","volume":"151","author":"Volkmar","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2015.03.011_bb1010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1469-7610.2008.02010.x","article-title":"Autism and autism spectrum disorders: diagnostic issues for the coming decade","volume":"50","author":"Volkmar","year":"2009","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2015.03.011_bb1015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","article-title":"Psychological and cardiovascular effects and short-term sequelae of MDMA (\u201cEcstasy\u201d) in MDMA-na\u00efve healthy volunteers","volume":"19","author":"Vollenweider","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2015.03.011_bb1020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0376-8716(01)00195-8","article-title":"Use, abuse and dependence of Ecstasy and related drugs in adolescents and young adults\u2014a transient phenomenon? Results from a longitudinal community study","volume":"66","author":"von Sydow","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb1025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.105.088476","article-title":"(\u00b1)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane","volume":"314","author":"Wang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb1030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijdevneu.2004.07.022","article-title":"Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?","volume":"23","author":"Whitaker-Azmitia","year":"2005","journal-title":"Int J Dev Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb1035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10567-009-0062-3","article-title":"Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with high-functioning autism","volume":"13","author":"White","year":"2010","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.03.011_bb1040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S0033291700053332","article-title":"Asperger's syndrome: a clinical account","volume":"11","author":"Wing","year":"1981","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2015.03.011_bb9925","first-page":"2271","article-title":"Conclusions: Guidelines for implementing the use of psychedelic medicines","volume":"Vol. 2","author":"Winkelman","year":"2007"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb1050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0269881106061514","article-title":"Vasopressin and oxytocin secretion in response to the consumption of Ecstasy in a clubbing population","volume":"20","author":"Wolff","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2015.03.011_bb1055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3109\/10550490903206049","article-title":"The variety of Ecstasy\/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions","volume":"18","author":"Wu","year":"2009","journal-title":"Am J Addict"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.03.011_bb1060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1077-7229(05)80056-2","article-title":"Long-term, multimodal treatment of a child with Asperger's syndrome and comorbid disruptive behavior problems: a case illustration","volume":"12","author":"Wymbs","year":"2005","journal-title":"Cogn Behav Pract"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:26:20Z","timestamp":1747866380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584615000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":184,"alternative-id":["S0278584615000603"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.03.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}